Latest GMOs Publications
Notification requirements for Part B application deliberate release of GMOs
Year: 2017
Notification requirements for the deliberate release of GMOs into the environment for purposes other than placing on the market i.e. for the performance of clinical/veterinary trials involving human/veterinary medicinal products containing or consisting of GMOs, or for the performance of field trials involving GM plants.
SNIF under Part 1 of Council Decision 2002/813/EC
Year: 2017
Part 1 of Council Decision 2002/813/EC relates to Summary Notification Information Format or SNIF for the release of GMOs other than higher plants
Guidance Note To Genetically Modified Organisms (Deliberate Release) Regulations
Year: 2017
This guidance note has been prepared to provide assistance and guidance to users of genetically modified organisms (GMOs) who wish to apply to the Environmental Protection Agency for consent to carry out a deliberate release of a GMO, for purposes other than placing on the market (eg field and clinical trials).
Information Notice - Positive GM test result on Oilseed Rape (OSR) Seed
Information note on details of a notification received by the EPA relating to a positive GM result on Oilseed Rape (OSR), September 2017
Year: 2017
A consignment of oilseed rape seed imported into Ireland for production of a commercial OSR crop tested positive for a GM element which is not authorised for cultivation in the EU. None of the OSR seed from this consignment was planted in Ireland.
GM Zebrafish - Information Notice
Information notice on the possible illegal import of genetically modified Zebrafish (Danio rerio), May 2017
Year: 2017
The EPA has been alerted to the unauthorised sale of GM Zebrafish (Danio rerio)in Denmark. The import and trade of GM zebrafish into the EU and the Republic of Ireland is illegal.
Confidential Information GMO Deliberate Release
Year: 2017
This guidance document sets out the procedure for submitting confidential information to the EPA under Article 10 of the GMO (Deliberate Release) Regulations S.I. No. 500 of 2003.
Final report under Commission Decision 2003/701/EC
Year: 2016
Final Report from Teagasc under Commission Decision 2003/701/EC
GMO Register Entry
Year: 2016
The GMO Register Entry G0208-01 provides significant details of the clinical trial.
Inspector's Report
Year: 2016
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in his report to the Board of the Agency.
Consent Conditions
Year: 2016
Consent Conditions G0208-01 issued to BASF Plant Science GmbH, Germany for the deliberate release into the environment of GM potatoes with improved resistance to potato blight for purposes other than placing on the market i.e. to perform field trials, from April to October 2006 to 2010. This trial did not proceed.
Teagasc End-of-year Report 2012
Year: 2015
End-of-year 2012 report in accordance with EPA licence G0469-01
Board Minute Extract
Year: 2014
An extract from the minutes of the EPA Board Meeting of 8 July 2014, at which The GUIDE Department's notification seeking consent to carry out a clinical trial at St James's Hospital, Dublin, was discussed.
G0536-01 GMO Register Entry
Year: 2014
The GMO Register entry provides significant details of the clinical trial.
G0536-01 Inspector's Report
Year: 2014
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency.
GMO Register No G0493-01
Year: 2014
The GMO Register entry provides significant details of the veterinary trial
Environmental Risk Assessment for AdCh3NSmut1
Year: 2014
Environmental Risk Assessment for Modified recombinant virus vaccine AdCh3NSmut1
Newspaper Notice, Southside People, 16 April 2014
Year: 2014
Newspaper Notice, Southside People, 16 April 2014